Clinical Observation of Dobutamine and Magnesium Sulfate in the Treatment of Chronic Pulmonary Heart Disease with Heart Failure
ZHANG De-liang
YUAN Jian-xi
Abstract：Objective:To observe the clinical effects of Dobutamine,Magnesium Sulfate in the treatment of chronic pulmonary heart disease with heart failure.Method:240 cases of chronic pulmonary heart disease with heart failure were randomly divided into the treatment group and the control group with 120 cases in each group,the control group using antibiotics,bronchodilators,strong heart diuresis,relieving cough,dispelling phlegm,oxygen inhalation, correct water,electrolyte,acid-base balance disorders of comprehensive treatment,the treatment group based on the treatment of the control group,disable the cardiotonic,diuretic,Dobutamine 60 mg,25% Magnesium Sulfate 10 ml,adding 5% Glucose Solution 300 ml,drip with 10-15 intravenous infusion per min.one time a day,for 7 consecutive days to 1 course of treatment.Result:After treatment,the total effectiveness of the treatment group was 95.0%,the control group was 66.7%,there had significant difference(P<0.01),the hemodynamics detection after treatment in two groups,the treatment group were better than those of control group(P<0.05).Conclusion:Dobutamine and Magnesium Sulfate in the treatment of chronic pulmonary heart disease heart failure are curative effect,less toxic side effect,can accelerate the relief of symptoms and improvement.
Keywords：DobutamineMagnesium SulfateChronic pulmonary heart failure
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：2( 43-44 )